News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Investor (World)
Lonza Group Ltd. (LZAGY.PK) Half-Year Business Performance Fully On Track 7/24/2014
Allergy Therapeutics plc Release: Notice Of Results And Trading Update 7/24/2014
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen 7/24/2014
IntelGenx Corp. To Host Management Call 7/21/2014
Ablynx (ABLYF) Announces Warrant Exercise 7/18/2014
BioAlliance Pharma Strengthens Its Financial Resources With The Support Of Its Top Shareholder 7/18/2014
Alcobra (ADHD) Discusses New Market Research And Updates On Recent Corporate Events At Investor Forum In New York City 7/17/2014
Leading U.S. Proxy Advisory Firm Supports Teva Pharmaceutical Industries Limited (TEVA) Nominees And Other Shareholders’ Meeting Proposals 7/16/2014
Euronext Introduces Spotlight Options On Ablynx (ABLYF) 7/15/2014
ErgoMed First Day Of Dealings On AIM 7/15/2014
Auspex Pharmaceuticals Announces Pricing Of Follow On Offering 7/14/2014
Newron Pharmaceuticals (NWRN) Shares To Be Included In The SXI Life Sciences® And The SXI Bio+Medtech® Indices 7/11/2014
TiGenix : Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 12 August 2014 7/10/2014
Fund Manager Dumps Biggest Investment Into AstraZeneca PLC (AZN) 7/9/2014
Cantargia’s Share Issue Of 20 MSEK Fully Subscribed 7/9/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 7/7/2014
Alcobra (ADHD) To Host Investor Forum And Webcast On July 15 In New York City 7/7/2014
Vitrolife (VITR.ST) Release: Conference Call Interim Report 7/2/2014
AstraZeneca PLC (AZN) CEO Wagers $3.4 Million On Shares 7/1/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 7/1/2014
Status Regarding Novo Nordisk A/S (NVO)'s Holding Of Its Own Shares (30 June 2014) 7/1/2014
TopoTarget A/S Release: Report Pursuant To The Danish Securities Trading Act, Section 28a 7/1/2014
TopoTarget A/S Release: New Articles Of Association Following Capital Increase 7/1/2014
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014
Shareholders Of Warnex Inc. (CC:WNX) Approve The Amalgamation With Diagnos Inc. (ADK) 6/27/2014
Endo International plc Announces Pricing Of Private Offering Of Senior Notes 6/26/2014
Endo International plc Announces Proposed Private Offering Of Senior Notes 6/25/2014
Prothena Corporation plc Announces Pricing Of Public Offering Of 4,750,000 Ordinary Shares 6/25/2014
Novo Nordisk A/S (NVO) Will Double Revenue Within A Decade: Deputy CEO 6/25/2014
Shire Release: PO Increased To 4500p. 6/25/2014
Prothena Corporation plc Announces Proposed Offering Of Ordinary Shares 6/24/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/23/2014
Neovasc Inc. (NVC) Announces Receipt Of Final Approval To Graduate To The TSX 6/20/2014
Covidien plc (COV) Release: Announcement Under Irish Takeover Rules Relevant Securities In Issue 6/20/2014
BioAlliance Pharma Has Received Pre-Approval For The Secondary Listing Of The Shares Of The Merged Company On NASDAQ OMX Copenhagen 6/20/2014
AstraZeneca PLC (AZN) Release: Director/PDMR Shareholding 6/19/2014
GW Pharmaceuticals Announces Proposed Public Offering Of ADSs 6/18/2014
China Biologic Products Announces Proposed Public Offering Of Common Stock 6/18/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/17/2014
Articles Of Association For Genmab A/S (GEN.CO) 6/16/2014
Grant Of Warrants To Genmab A/S (GEN.CO) Employees 6/13/2014
200,000 Orion Corporation A-Shares Converted Into B-Shares 6/13/2014
Actavis (ACT) Announces Receipt Of Requisite Consents And Expiration Of Consent Solicitations For Forest Laboratories, Inc. (FRX) Senior Notes 6/13/2014
Biohit B-Shares Subscribed With Stock Options I And II 2013 6/12/2014
Aurinia (ISA.TO) To Commence Trading On Toronto Stock Exchange 6/11/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 6/10/2014
Actavis (ACT) Announces Offering Of Senior Unsecured Notes 6/10/2014
Orexo AB (ORXOF) Publishes Bond Prospectus And Applies For Listing Of Its Bond Loan On NASDAQ OMX Stockholm 6/9/2014
Oriola-KD Corporation Recognizes EUR 74 Million Impairment Charge For Russian Pharmaceutical Wholesale Operating Segment 6/5/2014
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 6/5/2014
New Incentive Plans In The H. Lundbeck A/S (LUN.CO) Group 6/4/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 6/3/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/2/2014
Total Number Of Voting Rights And Share Capital In Bavarian Nordic (BAVA.CO) 6/2/2014
Total Number Of Voting Rights And Share Capital In H. Lundbeck A/S (LUN.CO) As Of 31 May 2014 6/2/2014
BioLineRx Ltd. Enters Into Share Purchase Agreement With Lincoln Park Capital 5/30/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 5/30/2014
Genmab A/S (GEN.CO)’s Total Number Of Voting Rights And Total Share Capital 5/29/2014
Report Of Transactions Of Shares And Related Securities Of Bavarian Nordic (BAVA.CO) By Persons Holding Managerial Responsibilities And/Or Persons/Companies Closely Associated With Such 5/29/2014
Bavarian Nordic (BAVA.CO) Issues New Shares In Connection With Exercise Of Warrants 5/27/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 5/27/2014
TopoTarget A/S Release: Notice To Convene Extraordinary General Meeting 5/27/2014
H. Lundbeck A/S (LUN.CO) Commences Tender Offer For All Outstanding Shares Of Chelsea Therapeutics, Inc. (CHTP) 5/23/2014
Annual General Meeting Of MorphoSys AG Approves All Proposals Of The Company's Management 5/23/2014
Veloxis Pharmaceuticals A/S (VELO) Release: Warrant Programme - New Articles Of Association 5/22/2014
ChinaBio(R) LLC Release: China To Stage Only 100 IPOS During The Rest Of 2014 5/22/2014
Clarification Regarding Pfizer Inc. (PFE) Statement 5/21/2014
H. Lundbeck A/S (LUN.CO) Increases Its Share Capital By 115,722 Shares (0.0590% Of Outstanding Shares) As A Result Of Employee Warrant Exercise 5/21/2014
Enzymotec Announces An Extraordinary General Meeting Of Shareholders To Approve Its Compensation Policy 5/21/2014
Ablynx (ABLYF) Release: Publication In Accordance With Article 14 Of The Belgian Law Of 2 May 2007 Regarding The Publication Of Major Shareholdings (The "Transparency Law") 5/20/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 5/19/2014
ProSensa Holding N.V. (RNA) Announces Shareholder Meeting 5/19/2014
Royal DSM - Repurchase Of Shares (9 - 15 May 2014) 5/16/2014
Report On Transactions With ALK-Abello A/S B-Shares And Associated Securities By Managerial Staff 5/12/2014
Rafarma Pharmaceuticals Commences Preparation Of Audited Financials 5/12/2014
BioTie Therapies Corp. Interim Report 1 January - 31 March 2014 5/9/2014
Oriola-KD Corporation: Notification On A Change In Ownership 5/9/2014
BioTie Therapies Corp.: Change In The Number Of Votes 5/9/2014
Resolutions From Swedish Orphan Biovitrumi's AGM 5/9/2014
AstraZeneca PLC (AZN) Shares Back On Rise Amid Fresh Bid Speculation 5/8/2014
Resolutions At The Annual General Meetings In Medivir AB (MVRBF) On 8 May 2014 5/8/2014
TopoTarget A/S Announces Interim Report For The Period January 1 - March 31, 2014 5/8/2014
Karo Bio AB Release: Interim Report January-March 2014 5/8/2014
ALK-Abello A/S Release: Three-Month Interim Report (Q1) 2014 5/8/2014
Trading In Novo Nordisk A/S (NVO) Shares By Board Members, Executives And Associated Persons On 7 May 2014 5/8/2014
Announcement Of Transactions With Shares And Linked Securities In H. Lundbeck A/S (LUN.CO) Made By Executives And Their Closely Associated Persons And Legal Entities 5/7/2014
Pluristem Therapeutics (PSTI) To Be Added To New TA Tech-Elite Stock Index In Israel 5/7/2014
Report From Annual General Meeting Of Vitrolife (VITR.ST) 5/6/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 5/6/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Announce Effectiveness Of Registration Statement On Form S-4 5/5/2014
Trading In Novo Nordisk A/S (NVO) Shares By Board Members, Executives And Associated Persons On 2 May 2014 5/5/2014
Trading In Novo Nordisk A/S (NVO) Shares By Board Members, Executives And Associated Persons On 1 May 2014 5/2/2014
Galapagos NV (GLPG.BR) Release: Invitation To The Extraordinary General Shareholders' Meeting To Be Held On 19 May 2014 5/1/2014
Norwegian Cancer Society To Invest Euros 0.5 Million In Vaccibody’s VB10.16 HPV Vaccine 5/1/2014
ALK-Abello A/S Announces An R&D And Business Briefing In NYC On 21 May 5/1/2014
Novo Nordisk A/S (NVO) Increased Operating Profit In Local Currencies By 15% In The First Quarter Of 2014 5/1/2014
Passing Of Zealand Pharma  (ZEAL.CO)’s Annual General Meeting 2014 4/30/2014
Change In The Number Of Shares And Votes In BioInvent (BOVNF) 4/30/2014
Neurosearch A/S (NEUR.CO) – Status Announcement For The Period 1 January To 31 March 2014 4/30/2014
Change Of The Number Of Shares And Votes In Karo Bio AB 4/30/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 4/30/2014
Total Number Of Voting Rights And Share Capital In Novo Nordisk A/S (NVO) As Of 30 April 2014 4/30/2014
Biotage AB (BIOTa.ST) – Changes In Number Of Shares And Votes 4/30/2014
Merck KGaA (MKGAF.PK): Form 8 (DD) - AZ Electronic Materials S.A. 4/30/2014
Olainfarm Release: Resolutions Of The Annual General Meeting Of Shareholders 4/29/2014
Zealand Pharma  (ZEAL.CO) - Interim Report For Q1 2014 (Un-Audited) 4/29/2014
Orion Corporation Interim Report January-March 2014 4/29/2014
BrainStorm Cell Therapeutics Inc. Announces Exchange Of Outstanding Warrants 4/28/2014
Merck KGaA (MKGAF.PK): Form 8 (DD) - AZ Electronic Materials S.A. 4/28/2014
Biotage AB (BIOTa.ST) Launches Share Buy-Back 4/28/2014
TopoTarget A/S Release: Passing On Annual General Meeting 4/25/2014
Active Biotech AB (BTPC) Interim Report January - March 2014 4/24/2014
Oriola-KD Corporation's Interim Report For 1 January-31 March 2014 4/24/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 4/23/2014
Novo Nordisk A/S (NVO) - Reduction Of The Share Capital 4/23/2014
Publishing Of Orion Corporation's Interim Report For January-March 2014 On 29 April 2014 4/22/2014
Genovis Annual General Meeting 4/22/2014
Sinovac Biotech Ltd. (SVA) Files 2013 Annual Report On Form 20-F 4/16/2014
Swedish Orphan Biovitrum Publishes Annual Report 2013 4/16/2014
300,000 Orion Corporation A-Shares Converted Into B-Shares 4/15/2014
Report From Orexo AB (ORXOF)’s Annual General Meeting, 15 April 2014 4/15/2014
Decisions Of The Annual General Meeting Of Biohit 4/14/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 4/14/2014
Active Biotech AB (BTPC) - Notice Of Annual General Meeting Of Shareholders 4/14/2014
Report Of Transactions In Zealand Pharma  (ZEAL.CO)’s Shares And Related Securities By Executives And Their Related Parties 4/11/2014
Vitrolife (VITR.ST) Release: Summary Annual Report 2013 In English 4/11/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Annual Report 2013 4/11/2014
Hansa Medical's Rights Issue Oversubscribed 4/11/2014
MorphoSys AG: Announcement Of The Convening Of The AGM In Munich/Germany On 23 May 2014 According To Sec. 121 Para. 4a Aktg With The Objective Of Europe-Wide Distribution 4/11/2014
Highlights From Innate Pharma (IPH.PA )'s R&D Update Today In New York 4/10/2014
BioPorto Release: Development Of Annual General Meeting 4/10/2014
Constitution Of The Board Of Directors In Genmab A/S (GEN.CO) And Grant Of Warrants To Employees 4/10/2014
Veloxis Pharmaceuticals A/S (VELO)- Passing Of Annual General Meeting 4/10/2014
Passing Of Genmab A/S (GEN.CO)’ Annual General Meeting 4/10/2014
Resolutions Of The Ordinary General Meeting Of Shareholders Of Basilea Pharmaceutica (BSLN.SW) 4/10/2014
Resolutions Of The Annual Shareholders' Meeting Of Sartorius AG 4/10/2014
Invitation To The AGM Of NeuroVive Pharmaceutical AB 4/10/2014
NeuroVive Pharmaceutical AB Stock Now Trading In The USA On The OTC Market 4/10/2014
Galapagos NV (GLPG.BR) Raises €2.4 Million Through Warrant Exercises 4/10/2014
Passing Of Genmab A/S (GEN.CO)’ Annual General Meeting 4/9/2014
Ipsen (IPN.PA) Eligible For PEA-PME And Included In CAC® PME Index By Euronext 4/9/2014
Notice Of Annual General Meeting In Karo Bio AB 4/8/2014
Medivir AB (MVRBF) Release: Annual Report 2013 4/7/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 4/7/2014
Annual Report 2013 Active Biotech AB (BTPC) 4/7/2014
Statement By The Board Of Directors Of Meda AB (MEDA-A.ST) 4/4/2014
Zealand Pharma  (ZEAL.CO) Announces Amendment To Its Articles Of Association Following Warrant Issuance 4/4/2014
BioTie Therapies Corp.: Change In The Number Of Votes 4/3/2014
Resolutions Of The Annual General Meeting Of BioTie Therapies Corp. And Organization Of The Board 4/3/2014
Notice Of Annual General Meeting In Swedish Orphan Biovitrum 4/3/2014
Meda AB (MEDA-A.ST)’s Annual Report Is Published 4/2/2014
NicOx SA (COX.PA) 2013 Financial Results And Business Update 4/2/2014
BiondVax Pharmaceuticals To Initiate The Process For Trading The Company's Shares In The U.S. Through ADR 4/2/2014
Status Regarding Novo Nordisk A/S (NVO)'s Holding Of Its Own Shares (31 March 2014) 4/1/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 4/1/2014
Zealand Pharma  (ZEAL.CO) Announces The Grant Of Warrants To Its Chief Scientific Officer Under Existing Incentive Scheme 4/1/2014
The Liquid Handling Business Acquisition Escrow Account Funds Returned To Biohit 4/1/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 4/1/2014
Genmab A/S (GEN.CO)’s Total Number Of Voting Rights And Total Share Capital 4/1/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 3/31/2014
Galapagos NV (GLPG.BR) Release: Invitation To The Annual And Extraordinary General Shareholders' Meetings To Be Held On 29 April 2014 3/31/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 3/31/2014
Royal DSM - Repurchase Of Shares (21 - 27 March 2014) 3/28/2014
TopoTarget A/S Release: Notice To Convene Annual General Meeting 2014 3/28/2014
H. Lundbeck A/S (LUN.CO) Held Its Annual General Meeting On 26 March 2014 At The Company's Registered Office 3/27/2014
New Incentive Plan For Executive Management In H. Lundbeck A/S (LUN.CO) 3/27/2014
Report On Annual General Meeting Held In Neurosearch A/S (NEUR.CO) 3/27/2014
Bavarian Nordic (BAVA.CO) - Notice Convening Ordinary General Meeting 3/27/2014
Biotage AB (BIOTa.ST) Publishes Its 2013 Annual Report And Corporate Governance Report 3/26/2014
Alcobra (ADHD) Announces Shares Uplisted To NASDAQ Global Market 3/26/2014
Trading In Novo Nordisk A/S (NVO) Shares By Board Members, Executives And Associated Persons On 24 March 2014 3/25/2014
Orexo AB (ORXOF)’s Annual Report For 2013 Released 3/25/2014
Veloxis Pharmaceuticals A/S (VELO) Release: Warrant Programme - New Articles Of Association 3/25/2014
Resolutions Of The Annual General Meeting Of Oriola-KD Corporation And The Decisions Of The Constitutive Meeting Of The Board Of Directors 3/25/2014
Publication Of Biohit Oyj Annual Report 2013 3/24/2014
Novo Nordisk A/S - Share Repurchase Programme 3/24/2014
Notice Of Annual General Meeting In BioInvent (BOVNF) 3/24/2014
Verona Pharma: Results Of Open Offer 3/24/2014
Novo Nordisk A/S (NVO): 2014 Long-Term, Share Based Incentive Programme For Novo Nordisk's Senior Management Board 3/21/2014
BioInvent (BOVNF): Annual Report 2013 3/21/2014
Novo Nordisk A/S (NVO): Resolutions From The Annual General Meeting 3/21/2014
Veloxis Pharmaceuticals A/S (VELO) Release: Warrant Programme - Registration Of Capital Increase And New Articles Of Association Following Warrant Exercise 3/20/2014
TopoTarget A/S Release: Teleconference Regarding Annual Report 2013 3/20/2014
Increased Number Of Biohit Shares Entered Into Trade Register 3/20/2014
Report On Management’s Transactions With ALK-Abello A/S B-Shares And Associated Securities 3/18/2014
ALK-Abello A/S Release: Grant Of Share Options To Members Of The Board Of Management And Key Employees 3/18/2014
Genmab A/S (GEN.CO) Summons Annual General Meeting 3/18/2014
Veloxis Pharmaceuticals A/S (VELO) Establishes New Warrant Programme 3/17/2014
Veloxis Pharmaceuticals A/S (VELO) Release: Notice To Convene Annual General Meeting 3/17/2014
Innate Pharma (IPH.PA ): R&D Update On April 10, 2014 In New York 3/17/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 3/17/2014
Royal DSM - Repurchase Of Shares (7 - 13 March 2014) 3/14/2014
Karo Bio AB Publishes Annual Report 3/14/2014
Capital Increase In Genmab A/S (GEN.CO) As A Result Of Employee Warrant Exercise 3/13/2014
Genmab A/S (GEN.CO) Release: Report Pursuant To Section 28a Of The Danish Securities Trading Act 3/13/2014
Biostar Pharmaceuticals, Inc. (BSPM) Announces Execution Of Agreement For $4.1 Million Registered Direct Offering Of Shares Of Common Stock And Warrants 3/11/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 3/10/2014
Pharming Group (PHGUF.PK) Reports On Preliminary Financial Results 2013 3/6/2014
Gentium S.p.A. Announces Decision To Voluntarily Delist American Depositary Shares From The NASDAQ Global Market 3/6/2014
Enzymotec Announces Closing Of Upsized Secondary Public Offering, Including Full Exercise Of The Underwriters' Option To Purchase Additional Shares 3/6/2014



//-->